BCL6 and lymphoma: One of the major limitations in understanding the pathogenesis of MYC/BCL6 DHL is the lack of in vitro and in vivo models by which unlimited supplies of lymphoma cells with concurrent MYC and BCL6 rearrangements can be studied repeatedly and extensively.